Feb 05, 2018

Fagron, Inc. Extends Pharmaceutical Ingredient Supply Chain To American Pharmaceutical Ingredients' Customers

American Pharmaceutical Ingredients to Shift Focus to Supplying US FDS Approved Finished Dosage Drugs

Fagron, Inc. was recently selected by American Pharmaceutical Ingredients (API) to directly service API's customers with continued supply of active ingredients for compounding.  With API's recent business decision to solely focus on the distribution of US FDA-approved finished dosage products, API's customers now have access to Fagron's extensive portfolio of bulk pharmaceutical ingredients, excipients, innovative creams, lotions, syrups, and suspending vehicles. 

"We conducted extensive research of the US-pharmaceutical market before identifying Fagron as a suitable option for our customers," states API Founder, Karl Jebailey, "Although API will no longer distribute bulk active ingredients, we wanted to ensure our customers receive the best turn-key solution for quality supply chain of compounding items." 

Fagron, Inc., a Fagron global company, sets the standard in premium quality. Based in St. Paul, MN, it is a US FDA and DEA-registered pharmaceutical manufacturer that strictly adheres to current Good Manufacturing Practices (cGMP). All batches are tested for identity, strength, quality, purity, and compliance with relevant USP or other monographs in Fagron's in-house analytical laboratory.

"We are thrilled with our collaboration with API," stated Ronaldo Steentjes, President Fagron, Inc., "As the compounding industry continues to evolve, we are proud to step in to help ensure customers continue to receive the high-quality pharmaceutical ingredients they expect and deserve."

About Fagron, Inc.
Fagron, Inc., an R&D scientific pharmaceutical compounding supplier, wants to widen the therapeutic scope of the prescriber to enable tailor-made pharmaceutical care. Through its activities, Fagron supports the unique selling point of the pharmacist and improves patients' quality of life. Contact Fagron, Inc. today at us.fagron.com.

About Fagron North America
Fagron North America is a group of innovative, scientific pharmaceutical companies that focus on optimizing and innovating personalized pharmaceutical care. As part of the world's leading pharmaceutical compounding company, operating in 34 countries, we act locally and think globally. Fagron North America is fully integrated with facilities that specialize in 503A Compounding, 503B Human Drug Outsourcing, and providing pharmacists with high-quality APIs, supplies, education and technical support. Fagron North America is headquartered in Nashville, TN. For more information, visit fagroncompanies.com.

About American Pharmaceutical Ingredients
American Pharmaceutical Ingredients LLC (API) is an FDA, DEA registered, and VAWD accredited national wholesale distributor of US FDA approved generics. For more information, visit www.AmericanAPI.com.

Market Buzz

Oct 17, 2018 Retail Management Solutions Celebrates 20 Years of Pharmacy POS Innovation
Oct 15, 2018 Transaction Data Systems Partners with Community Pharmacies to Fight the Opioid ...
Oct 10, 2018 Augusta University Health Selects Omnicell’s Industry-Leading Medication Manag...
Oct 04, 2018 QS/1® Honors Pharmacists at NCPA
Oct 03, 2018 Innovation to Move to New Campus in New York’s Southern Tier to Accommodate St...
Sep 23, 2018 Prudential Overall Supply Celebrates Dan Clark's 50th Employment Anniversary
Sep 19, 2018 RXQ Compounding Expanding in Albany
Sep 17, 2018 Middlesex Hospital Bolsters Pharmacy Safety and Compliance by Extending Wolters ...
Sep 14, 2018 Synergy Medical once again among Canada's Top 500 Companies
Sep 10, 2018 American Associated Pharmacies Taps FDS to Bring its Members a State-of-the-Art ...
Sep 10, 2018 Rees Scientific achieved ISO/IEC 17025:2017 Accreditation
Sep 06, 2018 Medical Packaging Inc. Named One of The Best Places to Work In New Jersey
Sep 06, 2018 Americorp Financial Launches New Brand, Website for Equipment Financing
Sep 04, 2018 Excelera® Specialty Pharmacy Network Announces Partnership with Smith & Nephew
Aug 30, 2018 Letco Medical, L.L.C. Announces Exclusive Partnership with Sweetgrass GxP Group,...
Aug 29, 2018 QS/1® Selected as Early Adopter in New CMS SCRIPT Standard
Aug 23, 2018 Innovations to Omnicell Patient Engagement Platform Support Value-Based, Patient...
Aug 14, 2018 ACHC and ExceleraRx Corp. Form Partnership
Aug 13, 2018 RetailSTARx with McKesson’s EnterpriseRx Supports ID Tracking for Controlled S...
Aug 07, 2018 Fagron, Inc. Announces New Hair Care Line - TrichoConcept™
Aug 03, 2018 Letco Medical, L.L.C. Launches Pharmacy Financial Services to Support Compoundin...
Aug 02, 2018 Beaumont Health Selects Omnicell’s Medication Management Platform and Services...
Jul 31, 2018 Lupin launches generic Desoximetasone Topical Spray, 0.25% in the US
Jul 25, 2018 NYU Langone Health Expands Strategic Partnership with Omnicell for Automated Med...
Jul 25, 2018 Prudential Cleanroom Services Hosts Ribbon Cutting Ceremony at Nashua, NH Cleanr...
Jul 18, 2018 Excelera® Specialty Pharmacy Network Announces Access to Breast Cancer Treatmen...
Jul 17, 2018 Multi-Store Independent Pharmacy Streamlines Operations with Epicor Eagle N Seri...
Jul 12, 2018 Acentrus Specialty Partners with CPPA for Specialty Pharmacy Practice Accreditat...
Jul 12, 2018 Letco Medical, L.L.C. Acquired by Current Management Team
Jul 10, 2018 Lorrie A. Carr Appointed as CEO for Excelera

RXinsider Product Overview Videos